这让她一度认为自己可能英年早逝。 在父母的鼓励下，她参加了一项CRISPR疗法临床试验。这项试验针对两种遗传性血液疾病：镰状细胞病和β-地中海 ...

Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin.

自从基因编辑策略CRISPR出现以来，它遇到了一个很大的限制：经典的CRISPR系统太笨重了，无法进入人体的许多组织并进行切片和切割。现在，加州大学伯克利分校的Jennifer Doudna因帮助开发CRISPR而获得2020年诺贝尔奖，她与人共同创立了一家公司，该公司的研究人员 ...

Suffering on such an immense scale can appear hopeless. However, a technique called CRISPR gene editing promises to help deal with these issues and many more—and wise regulation can spur it on.

研究人员优化 CRISPR/Cas9 系统编辑番茄 NAIP 基因家族，发现突变体幼年较矮，助力相关研究。 内质网体（ER Bodies）积累非典型黑芥子酶，该酶可水解硫代葡萄糖苷，产生对病原体和食草动物有毒的化学反应性产物。NAI2 是内质网体的一个组成部分，有助于内质网体 ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other shorted stocks in 2025.

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR technologies in the field of regenerative medicine. The study, authored by ...

CRISPR Therapeutics' stock is down 19% since December, with a slow Casgevy launch and significant R&D investments, yet strong cash reserves provide a safety net. Q4 earnings show no revenue from ...

the biotech would push forward CRISPR-based drugs for a series of liver and brain diseases, beginning by filing for a first trial in under two years. It was, suffice to say, bold. Arbor had yet ...

Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the CRISPR Market ...